For the quarter ending 2026-03-31, CBLL had $4,776K increase in cash & cash equivalents over the period. -$19,422K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Change in fair value of warrant liability | - | 0 | 0 | 0 |
| Net loss | -19,737 | -13,527 | -13,465 | -26,420 |
| Depreciation and amortization expense | 239 | 291 | 391 | 659 |
| Noncash lease expense | 11 | 25 | 26 | 50 |
| Stock-based compensation expense | 3,723 | 3,359 | 3,349 | 5,515 |
| Amortization of debt discount and accretion of premium on term loans | -6 | 107 | 106 | 202 |
| Accretion (amortization) of discount and premium on marketable securities | 555 | 622 | 902 | 487 |
| Loss on disposal of property and equipment and recorders | -34 | -25 | -29 | -50 |
| Accounts receivable, net | 659 | 2,819 | -78 | 1,434 |
| Inventory | -386 | 1,264 | 24 | -937 |
| Prepaid expenses and other current assets | -25 | 46 | 838 | -1,229 |
| Contract costs | -84 | 86 | 276 | 351 |
| Other non-current assets | -6 | 194 | -5 | 226 |
| Accounts payable | -857 | 589 | -205 | 1,361 |
| Accrued liabilities and other current liabilities | -1,956 | 3,475 | 765 | -17 |
| Contract liabilities | -13 | -37 | -85 | 96 |
| Net cash used in operating activities | -19,297 | -10,774 | -11,098 | -18,936 |
| Purchases of recorder components and recorders | 701 | 373 | 94 | 288 |
| Purchases of property and equipment | 125 | 179 | 369 | 219 |
| Purchases of marketable securities | 26,733 | 22,040 | 45,981 | 142,794 |
| Proceeds from maturities of marketable securities | 50,000 | 48,700 | 39,500 | 6,000 |
| Net cash provided by (used in) investing activities | 22,441 | 26,108 | -6,944 | -137,301 |
| Proceeds related to employee stock plans | 1,632 | 1,639 | 3,798 | - |
| Taxes withheld and paid related to settlement or vesting of equity awards | - | 236 | - | - |
| Proceeds from debt issuance | - | 0 | 0 | 0 |
| Debt issuance cost | 0 | 0 | 0 | 150 |
| Payment of deferred ipo offering costs | - | 0 | 0 | 0 |
| Proceeds from exercise of common stock pursuant to stock option exercises | - | - | - | 2,158 |
| Proceeds from ipo, net of commissions | - | 0 | - | - |
| Net cash provided by financing activities | 1,632 | 1,403 | 1,640 | 2,008 |
| Net increase (decrease) in cash and cash equivalents | 4,776 | 16,737 | -16,402 | -154,229 |
| Cash and cash equivalents, beginning of period | 40,476 | 23,739 | 194,370 | - |
| Cash and cash equivalents, end of period | 45,252 | 40,476 | 23,739 | - |
Ceribell, Inc. (CBLL)
Ceribell, Inc. (CBLL)